Schedule 13G ownership disclosure
SUNESIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 867328502
Event date: 2019-07-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-194012
- Form type
- SC 13G
- Filer
- Aisling Capital IV, LP
- CIK
- CIK 1652910
- Filed
- Jul 15, 2019
- Reporting period
- Jul 15, 2019
- Description
- Schedule 13G beneficial ownership